MENU
AGIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
540
Web
https://www.agios.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.75B
P/E Ratio
3.82
Total Cash
113.6M
Projected Growth
N/A
Total Debt
35.75M
Revenue
66.05M
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
1.91
Total Debt/Equity
N/A
Revenue/Share
1.13 USD as % of share price
View a ticker or compare two or three
AGIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
540
Web
https://www.agios.com